ArticleNature medicine2026
Citywide premarital genomic screening in a Middle Eastern population.
Article in Nature medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Middle East collaborative for undiagnosed diseases.Nature reviews. Genetics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
33 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Here we describe the feasibility and first implementation of a mandatory, citywide premarital genomic screening program comprising the sequencing of 782 genes, implicated in autosomal recessive disorders, in prospective couples enrolled through 18 primary healthcare centers throughout Dubai city. Since program inception, 1,000 couples have undergone testing, and 79 (8%, 95% confidence interval: 6.4-9.7) were identified as carriers of disease-causing variants in the same gene and, therefore, at risk of having affected children. This rate was significantly higher than that reported in the Australian Mackenzie's Mission study (3.9%; P < 0.0001). Although risk for hemoglobinopathies was most common, 59% of at-risk couples carried variants in 33 other genes. Of the 158 carriers, four (2.5%, 95% confidence interval: 1.0-6.3) were incidentally found to be homozygous for a pathogenic variant, indicating that they would be affected. Of the 79 at-risk couples, 63 (80%) elected to proceed with marriage while considering government-funded reproductive interventions, whereas 16 (20%) chose not to proceed. These findings underscore the feasibility and clinical utility of premarital genomic screening as part of a national strategy to reduce the burden of rare diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.